IHC staining of tumor tissues indicated that the expression of CyclinB1 and Cyclin E was significantly suppressed in the group treated with lenvatinib (Fig. 3e), which was consistent with the in vitro findings. The gene discussed is CCNE1; the disease is neoplasm.